SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Angiology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Schechter, D.
Right arrow Articles by Hardesty, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schechter, D.
Right arrow Articles by Hardesty, R. L.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ATENOLOL
*ENALAPRIL MALEATE
*HYDRALAZINE HYDROCHLORIDE
Medline Plus Health Information
*Blood Pressure Medicines
*Heart Transplantation
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Efficacy of Antihypertensive Medication in Orthotopic Heart Transplant Recipients and its Effect on Renal Function

David Schechter

From the University of Pittsburgh, Presbyterian-University Hospital, Pittsburgh, PA

Galal M. Ziady

From the University of Pittsburgh, Presbyterian-University Hospital, Pittsburgh, PA

Ann Lee

From the University of Pittsburgh, Presbyterian-University Hospital, Pittsburgh, PA

John M. Armitage

From the University of Pittsburgh, Presbyterian-University Hospital, Pittsburgh, PA

Robert L. Kormos

From the University of Pittsburgh, Presbyterian-University Hospital, Pittsburgh, PA

Bartley P. Griffith

From the University of Pittsburgh, Presbyterian-University Hospital, Pittsburgh, PA

Robert L. Hardesty

From the University of Pittsburgh, Presbyterian-University Hospital, Pittsburgh, PA

The authors looked at 77 patients following orthotopic heart transplant who received a triple immunosuppressive regimen including cyclosporine to see the effect of various antihypertensive medications on mean arterial blood pressure and renal function. There were 62 men and 15 women retrospectively classified into three groups according to the antihypertensive medications they received. Group 1 included 26 patients followed up for 10.7 ± 2.7 months who received hydralazine therapy. Group 2 included 32 patients followed up for 9.0 ± 3.4 months who received angiotensin-converting enzyme inhibition therapy. Group 3 included 19 patients followed up for 10.1 ± 3.3 months who received beta- adrenergic blocking agents. Mean arterial pressure (MAP), serum blood urea nitrogen (BUN), and serum creatinine (CR) were determined for each group at the start and end of the follow-up period. The MAP at the start of the study was 107 ± 14 in group 1,110 ± 13 in group 2, and 100 ± 11 in group 3. It was not statistically significantly different in any of the groups.

At the end of the follow-up period, MAP was 112 ± 10, 111 ± 10, and 106 ± 12 for the three groups respectively, and it was not significantly different in any group. The serum BUN in group 3 was 25 ± 8 mg/dL at the start of the study, and it was not significantly lower than that in group 1, 28 ± 6, but it was significantly different from that in group 2, 34 ± 9, P < 0.05. At the end of the follow-up period, the difference was still maintained. Moreover, it was signifi cantly different also from the BUN of group 1. The serum CR was 1.16 ± 0.25 at the start in group 3, and it was not significantly lower than that of either group 1 (1.27 ± 0.25) or group 2 (1.38 ± 0.37). There was a significant rise of serum CR levels in all groups over the duration of the follow-up (P < 0.05) re gardless of the antihypertensive therapy they received, however, CR of group 3 was significantly lower than that of groups 1 and 2 at the end of the follow-up.

The authors conclude that hypertension that develops after heart transplant is not easily controlled by medications. The deterioration in renal function over time is not related to the height of arterial blood pressure or to the antihyperten sive medications used.

Angiology, Vol. 43, No. 7, 585-589 (1992)
DOI: 10.1177/000331979204300707


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement